Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication pursuant to Regulation 47 of SEBI (Listing O...more...
Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Un-Audited Financial Results of the Company for the quarter and nine month ended on 31st December 2025more...
Outcome of Board Meeting held on Friday 13th February 2026more...
Significant movement in price has been observed in Biofil Chemicals & Pharmaceuticals Limited. The Exchange in order to ensure that investors have la...more...
Clarification on Price Movementmore...
The Exchange has sought clarification from Biofil Chemicals & Pharmaceuticals Ltd on February 3 2026 with reference to significant movement ...more...
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter ali...more...
As of December 2025 46.79% is owned by Indian Promoters and 53.21% by Public. Top five Promoters holding highest number of shares of Biofil ...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the qu...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tr...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passedmore...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publicationmore...
To review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2025 along with Limit...more...
The company reported standalone net profit of Rs 0.08 crore for the quarter ended September 30 2025 as compared to Rs 0.02 crore in the same...more...
Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
BOARD MEETINGS Company Name : Jash Engineering Date : 30-03-2026